Search Results 761-770 of 17469 for SC

  1. A Study Of The Effect Of The Vibrant Capsule On Gastric Emptying And Motility In Healthy Volunteers - Mayo Clinic

    Michael Camilleri, M.D., D.Sc. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information.

  2. Publications - Jerry D. Brewer, M.D., M.S. - Mayo Clinic

    Lalla SC, Kumar AB, Lehman JS, Lohse CM, Brewer JD. Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A ...

  3. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Why gastroenterologists and hepatologists should be involved in treating obesity. Mayo Clinic gastroenterologist Michael Camilleri, M.D., D.Sc., discusses the ...

  4. A Study To Evaluate Lumasiran In Children And Adults With Primary Hyperoxaluria Type 1 - Mayo Clinic

    History of intolerance to subcutaneous (SC) injection(s(. Is not willing to comply with the contraceptive requirements during the study period. Female ...

  5. Publications - Andrew C. Storm, M.D. - Mayo Clinic

    Epub 2023 May 16. View PubMed; Pawa S, Kwon RS, Fishman DS, Thosani NC, Shergill A, Grover SC, Al-Haddad M, Amateau SK, Buxbaum JL, Calderwood AH, Chalhoub ...

  6. C-section - Mayo Clinic

    Learn the reasons for this surgical procedure to deliver a baby, the risks and tips for recovery.

  7. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Inability to tolerate SC medication;; Inability to tolerate venipuncture;; Women who are breastfeeding;. Prior and concomitant therapy: Participants who have ...

  8. Publications - Caitlin B. Conboy, M.D., Ph.D. - Mayo Clinic

    ... SC, McIvor RS, Largaespada DA. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS One. 2014; 9 (5):e96114 Epub ...

  9. Lupus Clinical Trials - Mayo Clinic Research

    The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 ...

  10. Lymphoma - Doctors and departments - Mayo Clinic

    Sc.D., M.S.. Minnesota. McPhail, Ellen D. M.D.. Minnesota. Novak, Anne J. Ph.D. Minnesota. Paludo, Jonas M.D.. Minnesota. Porrata, Luis F. M.D.. Minnesota ...